U.S. Pharma Stock News

In its latest results, WillScot Holdings reported a 13% year-over-year decline in EBITDA, a similar drop in units on rent, and wrote off about 15% of its rental fleet, underscoring mounting financial and operational pressure. These fleet impairments and signs of tougher competition, particularly from United Rentals, point to a business mix tilting toward smaller, less profitable segments. Against this backdrop of fleet write-offs and weakening core metrics, we will assess how the news...

Why Brookfield Wealth Solutions is on investors’ radar today Brookfield Wealth Solutions (BNT) has been drawing attention after a period where the share price shows mixed returns across different time frames. This has prompted closer scrutiny of its business mix and current valuation. See our latest analysis for Brookfield Wealth Solutions. The latest 1 day share price return of a 0.4% decline and 90 day share price return of a 12% decline contrast with a 1 year total shareholder return of...

Wondering whether Vera Therapeutics at around US$40.45 is still offering value, or if the easy gains are behind it? This article is designed to help you frame that question clearly. The stock has returned 6.2% over the last week and 3.5% over the last month, while year to date it is down 16.8% but up 102.8% over the past year and a very large amount over three years. This naturally raises questions about what is already priced in. Recent coverage has focused on Vera Therapeutics as investors...

Some AnaptysBio, Inc. ( NASDAQ:ANAB ) shareholders may be a little concerned to see that the Independent Director, John...

Check Point Software Technologies Ltd. ( NASDAQ:CHKP ) just reported some strong earnings, and the market reacted...

If you are wondering whether Louisiana-Pacific at around US$72 a share is offering good value or is already pricing in a lot of expectations, this article will help you frame that question using several valuation lenses. The stock has been choppy recently, with a 2.6% gain over the last 7 days, a 7.2% decline over 30 days, and year-to-date returns showing an 11.7% decline, while the 3-year and 5-year returns sit at 35.5% and 22.4% respectively. Recent attention on Louisiana-Pacific has...

If you are wondering whether QuidelOrtho's current share price reflects its underlying value, this article walks through the key numbers that investors tend to focus on before making a decision. QuidelOrtho last closed at US$15.88, with returns of 4.1% over the past week, a 23.8% decline over the past month, and year to date and 1 year returns of 44.8% and 44.0% declines respectively. The 3 year and 5 year returns sit at 82.5% and 87.5% declines. These moves come as investors reassess the...

Amdocs recently extended its long-term relationship with T-Mobile under a new multi-year agreement covering managed services, software development, and AI innovation, while also expanding its engagement with Vodafone Germany, adding two western European clients, completing the Matrixx Software acquisition, and unveiling its telecom-focused aOS agentic operating system. Together, these moves point to Amdocs deepening its role at large carriers and broadening its telecom software capabilities...

The United States market has experienced a notable upswing, climbing 4.4% in the last week and an impressive 32% over the past year, with earnings projected to grow by 16% annually. In this environment, identifying stocks that may be undervalued requires a keen eye for potential growth and resilience amidst broader market gains, as highlighted by companies like BillionToOne and others.

The market has climbed 4.4% in the last 7 days and is up 32% over the last 12 months, reflecting strong investor confidence. For those looking to invest in smaller or newer companies, penny stocks—despite their somewhat outdated name—can still offer surprising value when backed by solid financial foundations. This article highlights several penny stocks that demonstrate financial strength and potential for long-term growth amidst current market conditions.

The United States market has shown impressive momentum, with a 4.4% increase over the last week and a remarkable 32% gain over the past year, while earnings are projected to grow by 16% annually. In this dynamic environment, identifying small-cap stocks with strong potential can offer unique opportunities for investors seeking to capitalize on emerging growth stories within the market.

Nelnet, Inc. recently entered into a new Credit Agreement for a US$435 million unsecured line of credit maturing on March 31, 2031, while terminating its prior US$495 million facility that was due in 2026 and carried no outstanding balance at the time. This refreshed, long-dated borrowing capacity, backed by customary financial covenants and subsidiary guarantees, underscores the company’s emphasis on maintaining flexible funding for general corporate purposes. With this extended US$435...

Key performance context for PayPay PayPay (PAYP) has drawn attention after a 10.37% one day decline and an 8.81% drop over the past week, prompting investors to reassess its fundamentals and recent share price moves. The company reports annual revenue of ¥355,530 and net income of ¥111,208, with revenue growth of 16.82% and net income growth of 5.77% in the most recent year, all in its reporting currency. See our latest analysis for PayPay. The recent 10.37% one day share price return decline...

In recent months, the Pennsylvania Public Utility Commission held public hearings and suspended UGI Utilities’ proposed natural gas distribution rate increase, which sought an 8.05% rise in annual operating revenues and would have lifted typical residential bills by about 8–9% to fund infrastructure, cybersecurity, and IT upgrades. This regulatory pushback highlights how strongly public sentiment and oversight can influence UGI’s ability to recover investment spending through higher rates, a...

Immunovant (IMVT) is back in focus after reporting that two Phase 3 studies of batoclimab in thyroid eye disease did not meet their primary endpoint, prompting a shift in attention toward its IMVT-1402 program. See our latest analysis for Immunovant. Despite the batoclimab setback, Immunovant’s recent 1-day and 7-day share price returns of 1.59% and 5.69% suggest some near term optimism. Its 72.97% 1-year total shareholder return keeps the longer term story firmly in focus. If you are...

Nexstar Media Group has recently completed a private fixed-income offering of US$1.73 billion in 7.250% senior unsecured notes due April 15, 2034, using the proceeds to redeem its 5.625% senior notes maturing in 2027 and to cover related fees and expenses. This refinancing reshapes Nexstar’s capital structure by extending debt maturities and adding guarantees and covenants that aim to enhance creditor protections and financial flexibility. Next, we’ll examine how Nexstar’s large 2034 senior...

Investors who take an interest in Epsilon Energy Ltd. ( NASDAQ:EPSN ) should definitely note that the President, Jason...

Investors may be wondering whether Archrock's current share price matches its underlying value, or if the recent buzz has pushed it ahead of itself. The stock recently closed at US$34.90, with a 1.2% move over the past week, a 1.2% decline over the past month, and returns of 31.1% year to date and 67.2% over the last year, while the 3 year and 5 year returns are described as very large. Recent coverage has focused on Archrock as an energy infrastructure company, with attention on how its...

Wondering if Customers Bancorp at around US$71.70 is still offering value or if most of the upside is already priced in? This article walks through what the current share price might be implying about the business. The stock has moved 6.6% over the last week and 6.3% over the last month, while year to date it is showing a 3.8% decline and a 65.2% return over the past year, with a very large 3 year return and a 114.5% return over 5 years. Recent coverage has focused on how regional banks are...

Why Golar LNG Is On Investors’ Radar Today Golar LNG (GLNG) has attracted fresh attention after a strong recent run in its share price, with gains over the past month and past 3 months prompting investors to reassess the LNG-focused business. See our latest analysis for Golar LNG. That recent momentum, including a 30 day share price return of 18.42% and a 90 day share price return of 48.27%, sits alongside a very strong 1 year total shareholder return of 76.06% and a multi year track record...

If you are wondering whether Uniti Group's current share price reflects its underlying value, the recent performance gives you plenty to think about. The stock last closed at US$10.30, with returns of 27.2% over the past week, 28.0% over the past month, 50.8% year to date, 41.1% over one year, 132.0% over three years and a 19.9% decline over five years. Recent news coverage has focused on Uniti Group as investors reassess telecom infrastructure plays and their role in income and growth...

Federal Realty Investment Trust extended its dividend growth streak to 58 consecutive years, keeping its place as the only REIT on the Dividend Kings list. The company continues to recycle capital by redeveloping higher potential properties and selling more mature assets. Shares of NYSE:FRT last closed at $106.78, with the stock up 2.2% over the past week and 29.0% over the past year. For investors watching income reliability, Federal Realty Investment Trust stands out, with a 58 year...

Wondering if Kulicke and Soffa Industries at about US$66.62 is priced for its recent momentum or leaving some value on the table? This breakdown will help you frame that question clearly. The stock has posted returns of 7.8% over the past week, 8.4% over the last month, 37.8% year to date and 132.2% over the past year, which can change how the market views both its potential and its risks. Recent coverage has focused on how semiconductor related names like Kulicke and Soffa Industries fit...

If you are wondering whether Teekay Tankers at around US$78.21 is still offering value or has already priced in the story, the key is to understand what current valuation signals are really saying about the stock. The share price has moved recently, with returns of 8.6% over the last 7 days, 8.9% over the last 30 days, 51.9% year to date, 116.8% over 1 year, 128.7% over 3 years, and a very large gain over 5 years. Recent news has focused on Teekay Tankers as an established player in the oil...